MA52739A - Endonucléases cpf1 mutantes - Google Patents

Endonucléases cpf1 mutantes

Info

Publication number
MA52739A
MA52739A MA052739A MA52739A MA52739A MA 52739 A MA52739 A MA 52739A MA 052739 A MA052739 A MA 052739A MA 52739 A MA52739 A MA 52739A MA 52739 A MA52739 A MA 52739A
Authority
MA
Morocco
Prior art keywords
mutant cpf1
cpf1 endonucleases
endonucleases
mutant
cpf1
Prior art date
Application number
MA052739A
Other languages
English (en)
Inventor
Guillermo Montoya
Stefano Stella
Original Assignee
Univ Copenhagen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Copenhagen filed Critical Univ Copenhagen
Publication of MA52739A publication Critical patent/MA52739A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/20Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA052739A 2018-06-04 2019-06-04 Endonucléases cpf1 mutantes MA52739A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18175707 2018-06-04
EP18190950 2018-08-27

Publications (1)

Publication Number Publication Date
MA52739A true MA52739A (fr) 2021-04-21

Family

ID=66676556

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052739A MA52739A (fr) 2018-06-04 2019-06-04 Endonucléases cpf1 mutantes

Country Status (12)

Country Link
US (2) US12152257B2 (fr)
EP (1) EP3802806A1 (fr)
JP (2) JP2021525541A (fr)
KR (1) KR20210028163A (fr)
CN (1) CN112424349A (fr)
AU (1) AU2019282094A1 (fr)
BR (1) BR112020024736A2 (fr)
CA (1) CA3102676A1 (fr)
IL (1) IL279153A (fr)
MA (1) MA52739A (fr)
MX (1) MX2020013229A (fr)
WO (1) WO2019233990A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
EP3823633A4 (fr) 2018-06-29 2023-05-03 Editas Medicine, Inc. Molécules de guidage synthétiques, compositions et procédés associés
CN111521781B (zh) * 2020-02-24 2021-07-30 广州医科大学附属第一医院(广州呼吸中心) 一种用于新冠肺炎病毒SARS-CoV-2核酸的检测试剂盒及其检测方法
JP7850156B2 (ja) * 2020-12-17 2026-04-22 モンサント テクノロジー エルエルシー 操作されたssDNase不含CRISPRエンドヌクレアーゼ
EP4284923A1 (fr) 2021-01-29 2023-12-06 Wageningen Universiteit Édition de bases associée à crispr du brin complémentaire
US20250025572A1 (en) * 2021-11-29 2025-01-23 Editas Medicine, Inc. Engineered crispr/cas12a effector proteins, and uses thereof
WO2023166030A1 (fr) 2022-03-01 2023-09-07 BASF Agricultural Solutions Seed US LLC Nickases cas12a
JP2025511267A (ja) 2022-03-30 2025-04-15 ビーエーエスエフ アグリカルチュラル ソリューションズ シード ユーエス エルエルシー 最適化塩基エディター
AU2023380182A1 (en) 2022-11-18 2025-07-03 Kyoto Prefectural Public University Corporation Compositions for mitophagy induction and uses thereof
WO2024133272A1 (fr) 2022-12-21 2024-06-27 BASF Agricultural Solutions Seed US LLC Efficacité d'édition accrue par co-administration de rnp avec un acide nucléique
US20250001010A1 (en) 2023-06-30 2025-01-02 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
US20250319206A1 (en) 2024-04-04 2025-10-16 Christina Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (fr) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Procédés d'identification et de corrélation de saut d'exon induit par crispr à des résultats phénotypiques
CN119506249B (zh) * 2024-11-29 2025-11-07 大连理工大学 一种多PAM选择的基因编辑系统NovaCas-1及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
US20190048340A1 (en) * 2015-09-24 2019-02-14 Crispr Therapeutics Ag Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
US12110490B2 (en) * 2015-12-18 2024-10-08 The Broad Institute, Inc. CRISPR enzymes and systems
EP3445853A1 (fr) 2016-04-19 2019-02-27 The Broad Institute, Inc. Complexes cpf1 à activité d'indel réduite
KR20260004568A (ko) 2016-04-19 2026-01-08 더 브로드 인스티튜트, 인코퍼레이티드 신규한 crispr 효소 및 시스템
CN106244591A (zh) * 2016-08-23 2016-12-21 苏州吉玛基因股份有限公司 修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
CN109790527A (zh) 2016-07-26 2019-05-21 通用医疗公司 普氏菌属和弗朗西斯氏菌属的CRISPR1(Cpf1)的变体
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
SG10201913505WA (en) 2016-10-17 2020-02-27 Univ Nanyang Tech Truncated crispr-cas proteins for dna targeting
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
WO2018195540A1 (fr) 2017-04-21 2018-10-25 The General Hospital Corporation Régulation de gène humain inductible, accordable et multiplex à l'aide de crispr-cpf1
US11591589B2 (en) 2017-04-21 2023-02-28 The General Hospital Corporation Variants of Cpf1 (Cas12a) with altered PAM specificity
WO2018209014A1 (fr) 2017-05-10 2018-11-15 Regents Of The University Of Minnesota Facteurs de transcription programmables et procédés
WO2018213726A1 (fr) 2017-05-18 2018-11-22 The Broad Institute, Inc. Systèmes, procédés et compositions d'édition ciblée d'acides nucléiques
US11866697B2 (en) 2017-05-18 2024-01-09 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
KR102655021B1 (ko) 2017-07-11 2024-04-04 시그마-알드리치 컴퍼니., 엘엘씨 표적된 게놈 변형을 개선하기 위한 뉴클레오솜 상호작용 단백질 도메인 사용
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US11649442B2 (en) 2017-09-08 2023-05-16 The Regents Of The University Of California RNA-guided endonuclease fusion polypeptides and methods of use thereof
WO2019075197A1 (fr) 2017-10-11 2019-04-18 The General Hospital Corporation Procédés de détection de désamination génomique parasite et spécifique de site induite par des technologies d'édition de base
US20210079366A1 (en) 2017-12-22 2021-03-18 The Broad Institute, Inc. Cas12a systems, methods, and compositions for targeted rna base editing
US11884947B2 (en) 2018-02-23 2024-01-30 Shanghaitech University Fusion proteins for base editing
KR102287880B1 (ko) 2018-03-26 2021-08-09 고쿠리츠다이가쿠호진 고베다이가쿠 세포에서 이중 가닥 dna의 표적 부위를 변형시키기 위한 방법
KR102922694B1 (ko) 2018-04-19 2026-02-03 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 유전자 편집을 위한 조성물 및 방법

Also Published As

Publication number Publication date
CA3102676A1 (fr) 2019-12-12
JP2021525541A (ja) 2021-09-27
US12152257B2 (en) 2024-11-26
CN112424349A (zh) 2021-02-26
EP3802806A1 (fr) 2021-04-14
BR112020024736A2 (pt) 2021-03-23
JP2025075025A (ja) 2025-05-14
US20210230567A1 (en) 2021-07-29
IL279153A (en) 2021-01-31
US20250163394A1 (en) 2025-05-22
WO2019233990A1 (fr) 2019-12-12
KR20210028163A (ko) 2021-03-11
MX2020013229A (es) 2021-04-28
AU2019282094A1 (en) 2021-01-07

Similar Documents

Publication Publication Date Title
MA52739A (fr) Endonucléases cpf1 mutantes
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
IL280913A (en) Novel methods
IL280912A (en) Novel methods
EP3890716A4 (fr) Polythérapies
EP3846674C0 (fr) Spéculum vaginal
EP3849534A4 (fr) Polythérapies
EP3555124C0 (fr) Tcr nyeso
EP3781060A4 (fr) Cryosonde
EP3784463A4 (fr) Fluorosulfones
EP3872558A4 (fr) Optoisolateur
EP3810860C0 (fr) Coupleur
EP3792200A4 (fr) Conteneur-citerne
EP3745904C0 (fr) Poignée de bâton
EP3878374A4 (fr) Dispositif d'occlusion
DOS2019000134S (es) Ornamentacion
EP3721129C0 (fr) Cryosphère
DOS2019000137S (es) Ornamentación
EP3844177A4 (fr) Polythérapies
DOS2019000138S (es) Ornamentacion
DOS2019000133S (es) Ornamentación
DOS2019000135S (es) Ornamentación
DOS2019000136S (es) Ornamentacion
DK3587968T3 (da) Fluidsystem